CDTG: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	18m	30m	34m	29m
Cost of revenue	11m	19m	23m	19m
Gross profit	8m	11m	11m	10m
Research and development	47,602	61,786	80,948	112,668
Selling, general and administrative	2m	3m	3m	3m
Operating expenses	19m	9m	3m	4m
Operating income	−12m	2m	9m	6m
Interest expense	91,446	136,757	106,130	64,658
Pre-tax income	−12m	2m	8m	6m
Income tax	−1m	462,043	1m	1m
Net income	−10m	1m	7m	6m
Earnings per share	−0.84	0.14	0.81	0.63
Earnings per share, diluted	−0.84	0.14	0.81	0.63
Weighted average shares	12m	10m	9m	9m
Weighted average shares, diluted	12m	10m	9m	9m

Metric	Aug 19, 2026	Aug 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash and equivalents	—	—	66,686	124,379	268,102	199,864	1m
Receivables	—	—	44m	45m	29m	—	—
Current assets	—	—	84m	78m	65m	—	—
Property, plant and equipment	—	—	1m	1m	2m	—	—
Total assets	—	—	89m	89m	73m	—	—
Current liabilities	—	—	58m	52m	41m	—	—
Total liabilities	—	—	58m	52m	41m	—	—
Equity	—	—	31m	37m	32m	26m	22m
Shares outstanding	—	—	—	11m	9m	—	—
Shares issued	—	—	—	11m	9m	—	—

Metric	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Operating cash flow	−1m	−2m	−3m	−4m
Depreciation and amortisation	235,099	263,109	331,336	383,827
Share-based compensation	2m	454,250	—	—
Capital expenditure	2,233	3,893	21,550	53,187
Investing cash flow	1,067	545,167	243,586	−94,452
Financing cash flow	1m	1m	3m	4m